Effect of the specific cyclooxygenase-2 inhibitor meloxicam on tumour growth and cachexia in a murine model

International Journal of Cancer

Volumn 87, Issue 1, 2000, Pages 95-100

  Hussey, H J ^b   Tisdale, M J ^a  

^a ASTON UNIVERSITY   (United Kingdom)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2 INHIBITOR; MELOXICAM;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CACHEXIA; CONTROLLED STUDY; DRUG EFFECT; ENZYME SPECIFICITY; GROWTH INHIBITION; MOLECULAR CLONING; MOUSE; MUSCLE MASS; MYOBLAST; NONHUMAN; PRIORITY JOURNAL; PROTEIN DEGRADATION; SECOND MESSENGER; TUMOR GROWTH; TUMOR VOLUME; TUMOR XENOGRAFT;

ADENOCARCINOMA; ANIMALS; BODY WEIGHT; CACHEXIA; COLONIC NEOPLASMS; CYCLOOXYGENASE 2; CYCLOOXYGENASE 2 INHIBITORS; CYCLOOXYGENASE INHIBITORS; DOSE-RESPONSE RELATIONSHIP, DRUG; ISOENZYMES; MALE; MICE; MICE, INBRED STRAINS; NEOPLASM TRANSPLANTATION; PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES; THIAZINES; THIAZOLES; TIME FACTORS;

EID: 0009088730     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(20000701)87:1<95::AID-IJC14>3.0.CO;2-D     Document Type: Article

References (32)

1. BECK, S.A. and TISDALE, M.J., Production of lipolytic and proteolytic factors by a murine tumor-producing cachexia in the host. Cancer Res., 47, 5919-5923 (1987).
2. BIBBY, M.C., DOUBLE, J.A., ALI, S.A., FEARON, K.C.H., BRENNAN, R.A. and TISDALE, M.J., Characterisation of a transplantable adenocarcinoma of the mouse producing cachexia in recipient animals. J. nat. Cancer Inst., 78, 539-546 (1987).
3. CHAN, G., BOYLE, J.O., YANG, E.K., ZHANG, F., SACKS, P.G., SHAH, J.P., EDELSTEIN, D., SOSLOW, R.A., KOKI, A.T., WOERNER, B.M., MASFERRER, J.L. and DANNENBERG, A.J., Cyclooxygenase-2 expression is up-regulated in squamous cell carcinoma of the head and neck. Cancer Res., 59, 991-994 (1999).
4. DEWITT, D.L. and SMITH, W.L., Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence. FEBS Lett., 231, 347-351 (1988).
5. DOUBLE, J.A. and BIBBY, M.C., Therapeutic index: a vital component in selection of anticancer agents for clinical trial. J. nat. Cancer Inst., 81, 988-994 (1989).
6. EBERHART, C.E., COFFEY, R.J., RADHIKA, A., GIARDIELLO, F.M., FERRENBACH, S. and DUBOIS, R.N., Up-regulation of cyclooxygenase-2 gene expression in human colorectal adenomas and adenocarcinomas. Gastroenterology, 107, 1183-1188 (1994).
7. GIOVANNUCCI, E., EGAN, K.M., HUNTER, D.J., STAMPFER, M.J., COLDITZ, G.A., WILLET, W.C. and SPEIZER, F.E., Aspirin and the risk of colorectal cancer in women. N. Engl. J. Med., 333, 609-614 (1995).
8. GOLDMAN, A.P., WILLIAMS, C.S., SHENG, H., LAMPS, L.W., WILLIAMS, V.P., PAIRET, M., MORROW, J.D. and DUBOIS, R.N., Meloxicam inhibits the growth of colorectal cancer cells. Carcinogenesis, 19, 2195-2199 (1998).
9. HIDA, T., YATABE, Y., ACHIWA, H., MURAMATSU, H., KOZAKI, K.-I., NAKAMURA, S., OGAWA, M., MITSUDOMI, T., SUGIURA, T. and TAKAHASHI, T., Increased expression of cyclooxygenase-2 occurs frequently in human lung cancers, specifically in adenocarcinomas. Cancer Res., 58, 3761-3764 (1998).
10. HUSSEY, H.J. and TISDALE, M.J., Effect of polyunsaturated fatty acids on the growth of murine colon adenocarcinomas in vitro and in vivo. Brit. J. Cancer, 70, 6-10 (1994).
11. HWANG, D., SCOLLARD, D., BYRNE, J. and LEVINE, E., Expression of cyclooxygenase-1 and cyclooxygenase-2 in human breast cancer. J. nat. Cancer Inst., 90, 455-460 (1998).
12. JONES, D.A., CARLTON, D.P., MCINTYRE, T.M., ZIMMERMAN, G.A. and PRESCOTT, S.M., Molecular cloning of human prostaglandin endoperoxide synthase type II and demonstration of expression in response to cytokines. J. biol. Chem., 268, 9049-9054 (1993).
13. KARGMAN, S.L., O'NEILL, G.P., VICKERS, P.J., EVANS, J.F., MANCINI, J.A. and JOTHY, S., Expression of prostaglandin G/H synthase-1 and -2 protein in human colon cancer. Cancer Res., 55, 2556-2559 (1995).
14. KAWAMORI, T., RAO, C.V., SEIBERT, K. and REDDY, B.S., Chemopreventative activity of Celecoxib, a specific cyclooxygenase-2 inhibitor against colon carcinogenesis. Cancer Res., 58, 409-412 (1998).
15. KUJUBU, D.A., FLETCHER, B.S., VARNUM, B.C., LIM, R.W. and HERSCHMAN, H.R., TISIO, a phorbol ester tumor promoter-inducible mRNA from Swiss 3T3 cells encodes a novel prostaglandin synthase/cyclooxygenase homologue. J. biol. Chem., 266, 12866-12872 (1991).
16. LORITE, M.J., CARIUK, P. and TISDALE, M.J., Induction of muscle protein degradation by a tumour factor. Brit. J. Cancer, 76, 1035-1040 (1997).
17. LORITE, M.J., THOMPSON, M.G., DRAKE, J.L., CARLING, G. and TISDALE. M.J., Mechanism of muscle protein degradation induced by a cancer cachectic factor. Brit. J. Cancer, 78, 850-856 (1998).
18. MCMILLAN, D.C., WIGMORE, S.J., FEARON, K.C.H., O'GORMAN, P., WRIGHT, C.E. and MCARDLE, C.S., A prospective randomized study of megestrol acetate and ibuprofen in gastrointestinal cancer patients with weight loss. Brit. J. Cancer, 79, 495-500 (1999).
19. PAIRET, M., VAN RYN, J., SCHIEROK, H., MAUZ, A., TRAMMLITZ, G. and ENGELHARDT, G., Differential inhibition of cyclooxygenase-1 and -2 by meloxicam and its 4′-isomer. Inflamm. Res., 47, 270-276 (1998).
20. SCHEIMAN, J.M., NSAIDs, gastrointestinal injury and cytoprotection. Gastroenterol. Clin. N. Amer. 25, 279-298 (1996).
21. SCHREINEMACHERS, D.M. and EVERSON, R.B., Aspirin use and lung, colon and breast cancer incidence in a prospective study. Epidemiology, 5, 138-146 (1994).
22. SHENG, H., SHAO, J., KIRKLAND, S.C., ISAKSON, P., COFFEY, R., MORROW, J., BEAUCHAMP, R.D. and DUBOIS, R.N., Inhibition of human colon cancer cell growth by selective inhibition of cyclooxygenase-2. J. clin. Invest., 99, 2254-2259 (1997).
23. STRELKOV, A.B., FIELDS, A.L.A. and BARACOS, V.E., Effects of systemic inhibition of prostaglandin production on protein metabolism in tumour-bearing rats. Amer. J. Physiol., 257, C261-C269 (1989).
24. SUBBARAMAIAH, K., ZAKIM, D., WEKSLER, B.B. and DANNENBERG, A.J., Inhibition of cyclooxygenase: a novel approach to cancer prevention. Proc. Soc. exper. Biol. Med., 216, 201-210 (1997).
25. TESSITORE, L., COSBELLI, P. and BACCIAO, P.M., Pharmacological interference with tissue hypercatabolism in tumour-bearing rats. Biochem. J., 299, 71-78 (1994).
26. TIANO, H., CHULADA, P., SPALDING, J., LEE, C., LOTRIN, C., MAHLER, J., MORHAM, S. and LANGENBACH, R., Effects of cyclooxygenase deficiency on inflammation and papilloma development in mouse skin. Proc. Am. Assoc. Cancer Res., 38, 1727 (1997).
27. TODOROV, P., CARIUK, P., MCDEVITT, T., COLES, B., FEARON, K. and TISDALE, M., Characterization of a cancer cachectic factor. Nature (Lond.), 379, 739-742 (1996).
28. TODOROV, P.T., DEACON, M. and TISDALE, M.J., Structural analysis of a tumor-produced sulfated glycoprotein capable of initiating muscle protein degradation. J. biol. Chem., 272, 12279-12288 (1997).
29. TSUJII, M. and DUBOIS, R.N., Alterations in cellular adhesion and apoptosis in epithelial cells overexpressing prostaglandin endoperoxide synthase-2. Cell, 83, 493-501 (1995).
30. TUCKER, O.N., DANNENBERG, A.J., YANG, E.K., ZHANG, F., TENG, L., DALY, J.M., SOSLOW, R.A., MASFERRER, J.L., WOERNER, B.M., KOKI, A.T. and FAHEY III, T.J., Cyclooxygenase-2 expression is up-regulated in human pancreatic cancer. Cancer Res., 59, 987-990 (1999).
31. WIGMORE, S.J., ROSS, J.A., FALCONER, J.S., PLESTER, C.E., TISDALE, M.J., CARTER, D.C. and FEARON, K.C.H., The effect of polyunsaturated fatty acids on the progress of cachexia in patients with pancreatic cancer. Nutrition, 12, S27-S30 (1996).
32. YOKOYAMA, C., TAKAI, T. and TANABE, T., Primary structure of sheep prostaglandin endoperoxide synthase deduced from cDNA sequence. FEBS Lett., 231, 347-351 (1988).